Month: March 2026

Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) — HeartSciences Inc.  (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), will present at Investor Summit Group Virtual Conference, March 25, 2026 at 12:30 pm ET. Hosted by Investor Summit Group, a premier platform connecting microcap companies with leading investors, the event provides a highly efficient forum for emerging growth companies to engage directly with institutional investors, family offices, and high-net-worth individuals. Event Details:Conference: Investor Summit Group Virtual Conference Format: Virtual Presentations & One-on-One Investor Meetings Presentation Date: March 25, 2026 Presentation...

NEWPORT NEWS, Va., March 24, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today the selection of two vice presidents at its Newport News Shipbuilding (NNS) division. Christie Miller has been promoted to the role of vice president of communications and Christian Ortego will join the division as vice president and NNS chief counsel. In her new role, Miller will have responsibility for internal and executive communications, special events and protocol, and tradeshows and tours for NNS. Starting her career with the company in 2011, Miller has held positions of increasing responsibility, including corporate manager of media relations, executive communications manager and most recently director of communications at NNS. Before joining HII, Miller worked in government communications and as a journalist. She holds a bachelor’s degree...

Vaisala CorporationStock exchange releaseMarch 24, 2026, at 4:30 p.m. (EET) Resolutions by the Vaisala Corporation Annual General Meeting and the Board of Directors Vaisala Corporation’s Annual General Meeting was held on March 24, 2026. The meeting approved the financial statements and discharged the members of the Board of Directors and the President and CEO from liability for the financial period January 1–December 31, 2025. DividendThe Annual General Meeting resolved a dividend of EUR 0.86 per share. The record date for the dividend payment is March 26, 2026, and the payment date is April 2, 2026. Board of Directors The Annual General Meeting confirmed that the number of Board members is seven. Annica Bresky, Antti Jääskeläinen, Kaarina Ståhlberg, Tuomas Syrjänen, Raimo Voipio and Ville Voipio will continue as members of the Board...

ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING24 MARCH 2026 at 16.30 EET         Decisions taken by Orion Corporation’s Annual General Meeting and Board of Directors’ organising meeting on 24 March 2026 At the Annual General Meeting of Orion Corporation held today, the following decisions were made:A dividend of EUR 1.80 per share was confirmed to be paid. The dividend is paid in two instalments. The proposals concerning the election and remuneration of the Board of Directors, the election and remuneration of the auditor and the sustainability reporting assurance provider, and the number of the members of the Board of Directors were approved. Kari Jussi Aho, Ari Lehtoranta, Veli-Matti Mattila, Hilpi Rautelin, Henrik Stenqvist and Karen Lykke Sørensen were re-elected to the Board of Directors. Minna...

Iceland Seafood has published its Annual and ESG Report for the year 2025.In line with our sustainability efforts, the report will be available exclusively on our website this year and going forward, as we have discontinued printed copies to reduce our environmental footprint. Direct link to the report is here: 2025 Annual Report – ISI – Iceland Seafood ESG Performance – ISI – Iceland Seafood

Zealand Pharma research hub35 CambridgePark Drive (4th floor), Cambridge, MassachusettsPress release – No. 6 / 2026 Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation New research hub in Cambridge, Massachusetts, in the greater Boston area, expands global discovery capabilities, combining Zealand Pharma’s more than 25 years of expertise in peptides and metabolic health with Boston’s biotech innovation ecosystem. Copenhagen, Denmark and Boston, Massachusetts, March 24, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today announced the establishment of a new research hub in Cambridge, Massachusetts, in the greater Boston area. The facility will serve...

TEL AVIV, ISRAEL, March 24, 2026 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (NASDAQ: PRZO) (the “Company”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced the closing of its previously announced registered direct offering with a single institutional investor for the purchase and sale of approximately $4 million of ordinary shares and pre-funded warrants at a price of $0.75 per ordinary share. The offering consisted of the sale of 5,333,333 ordinary shares (or pre-funded warrants) at a public offering price of $0.75 per ordinary share (or $0.74999 for each pre-funded warrant, which is equal to the public offering price per ordinary share sold in the offering minus an exercise price of $0.00001 per pre-funded warrant). The pre-funded...